Delaware | 001-34525 | 30-0349798 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Item 9.01 | Financial Statements and Exhibits. |
10.1 | Offer Letter, effective as of November 16, 2015, by and between Erin Energy Corporation and Jean-Michel Malek. |
ERIN ENERGY CORPORATION | ||
By: | /s/ Daniel Ogbonna | |
Daniel Ogbonna | ||
Senior Vice President and Chief Financial Officer | ||
Date: November 18, 2015 |
Re: | Offer of Employment as Senior Vice President, General Counsel and Corporate Secretary |
a. | During the term of your employment with the Company you will receive a base salary of US$291,000.00 per annum (the “Base Salary”), paid in arrears and in equal installments in accordance with the customary payroll practices of the Company. |
b. | The Company will recommend that the Board approve for you to receive an option to purchase 133,334 shares of the Company’s common stock (the “Option”) under the Company’s 2009 Equity Incentive Plan (the “Plan”). The Option will be evidenced by an Option Agreement as contemplated by the Plan, which will govern the Option, notwithstanding any other provision in this Agreement. The exercise price of the Option will be the closing price of the Company’s common stock on your date of hire. The Option will vest in equal 1/3 annual installments on first three anniversary dates of your date of hire, subject to your continued service with the Company on such anniversary dates. |
c. | The Company will recommend that the Board approve for you to receive 29,167 restricted shares of the Company’s common stock (the “Stock”) under the Plan. The Stock will be issued pursuant to a Restricted Stock Award Agreement as contemplated by the Plan, which will govern the Stock and your rights to the Stock, notwithstanding any other provision in this Agreement. The Stock shall be restricted and subject to forfeiture to the Company if your rights to the restricted Stock do not vest under the award agreement. Your rights to the Stock will vest with respect to 50% of the Stock on the one-year anniversary of your date of hire, and will vest with respect to the balance on the two-year anniversary of your date of hire, subject in both cases to your continued service with the Company on such anniversary date. |
d. | You will be reviewed by your supervisor and the Board, not less than annually, and in connection with such review, will be eligible for a discretionary cash performance bonus each year targeted at between 0% to 100% of your then-current annual base salary, based on defined targets determined by your supervisor and the Board. You shall also be considered for additional grants of restricted stock and options in the Board’s sole discretion. You acknowledge that the Company is not obligated to award you any cash or equity bonus in any year. |
a. | You shall be eligible to participate in the employee benefit plans, programs and policies maintained by the Company for similarly situated employees in accordance with the terms and conditions of such plans, programs, and policies as in effect from time to time. |
b. | In accordance with and subject to the terms of the Company’s expense reimbursement policy, the Company shall pay or reimburse you for reasonable expenses actually incurred or paid by you in the performance of your services hereunder upon the presentation of expense statements or vouchers or such other appropriate supporting information as the Company may reasonably require of you. To the extent that a reimbursement amount is subject to section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), and the rules and regulations issued thereunder by the Department of Treasury and the Internal Revenue Service (“Section 409A”) the Company will pay you the reimbursement amount due, if any, in any event before the last day of your taxable year following the taxable year in which the expense was incurred. Your rights to any reimbursements are not subject to liquidation or exchange for another benefit. The amount of expense reimbursements for which you are eligible during any taxable year will not affect the amount of any expense reimbursements for which you are eligible in any other taxable year. |
c. | You will be entitled to up to 28 days of paid time off per annum (pro-rated for partial years of service) in addition to the normal statutory holidays, provided, however, that vacation is to be taken at such times and intervals as may be agreed by the Company having regard to your workload and needs of the Company. |
d. | You shall be entitled to the benefit of the indemnification provisions contained in the bylaws of the Company, as the same may be amended. |
a. | With or without cause, you and the Company may each terminate this Agreement at any time after thirty (30) days advance written notice, and the Company will be obligated to pay you the compensation and expenses due up to the date of your Separation from Service. Notwithstanding the foregoing sentence, the Company will pay to you an amount equal to the Base Salary plus target annual bonus as determined by the Board for the year in which Separation from Service occurs (the “Separation Payment”) if you incur a Separation from Service due to your termination by the Company without “Cause” and shall also provide the benefits described in Section 9.b. below, and immediately accelerate by twelve (12) months the vesting of all outstanding Company restricted stock and options exercisable for Company Stock then held by you, with all vested Company options held by you (including accelerated options) remaining exercisable for a period of twelve (12) months following your date of Separation from Service, in exchange for a full and complete release of claims against the Company, its affiliates, officers and directors in a form reasonably acceptable to the Company (the “Release”), which Release has become irrevocable. For purposes of this provision, “Cause” means your (i) conviction of, or plea of nolo contendere to, a felony or any other crime involving moral turpitude; (ii) fraud on or misappropriation of any funds or property of the Company or any of its affiliates, customers or vendors; (iii) willful violation of any applicable law, rule or regulation (other than minor traffic violations or similar offenses), or breach of fiduciary duty; (iv) willful failure to perform your responsibilities in the best interests of the Company or any of its affiliates; (v) illegal use or distribution of drugs; (vi) material violation of any rule, regulation, procedure or policy of the Company or any of its affiliates; or (vii) material breach of any provision of this Agreement or any other employment, non-disclosure, non-competition, non-solicitation or other similar agreement executed by you for the benefit of the Company or any of its affiliates, all as determined by the Board or the Company’s affiliate (as the case may be), which determination will be conclusive. The Separation Payment is intended to qualify as separation pay due to involuntary Separation from Service under Treasury Regulation §1.409A-1(b)(9)(iii). To the extent the Separation Payment, or any portion thereof, so qualifies or is otherwise exempt from the requirements of Section 409A, such amount shall be paid in 12 equal monthly installments on the last day of each of the first 12 months following the month of your Separation from Service, subject |
b. | If (i) your employment with the Company is terminated by the Company without “Cause” as described in Section 9(a), (ii) you are an active participant in the Company’s group medical plan (the “Group Medical Plan”) on the date of your employment terminates, (iii) you timely elect to continue that Group Medical Plan coverage under section 4980B of the Code (“COBRA Continuation Coverage”), and (iv) you execute and do not revoke the Release, the Company will reimburse you, the excess, if any, of the amount you pay to the Company for such COBRA Continuation Coverage for up to the first 12 months you maintain such COBRA Continuation Coverage, above the amount of the applicable premium that you would have paid for comparable coverage during such 12 month period if you had remained an employee of the Company during such 12 month period. Any reimbursements by the Company to you required under this Section 9.b shall be made on the last day of each month you pay the amount required by this Section 9.b to the Company for such COBRA Continuation Coverage, for up to the first 12 months of COBRA Continuation Coverage. If you are a Specified Employee and the benefits specified in this Section 9.b are taxable to you and not otherwise exempt from Section 409A, the following provisions shall apply to the reimbursement or provision of such benefits. Any amounts to which you would otherwise be entitled under this Section 9.b during the first six months following the date of your Separation from Service shall be accumulated and paid to you on the date that is six months following the date of your Separation from Service. Except for any reimbursements under the applicable group health plan that are subject to a limitation on reimbursements during a specified period, the amount of expenses eligible for reimbursement under this Section 9.b, or in-kind benefits provided, during your taxable year shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year of yours. Any reimbursement of an expense described in this Section 9.b shall be made on or before the last day of your taxable year following your taxable year in which the expense was incurred. Your right to reimbursement or in-kind benefits pursuant to this Section 9.b shall not be subject to liquidation or exchange for another benefit. Subject to your Group Medical Plan COBRA Coverage Continuation rights under section 4980B of the Code, the benefits listed in this Section 9.b shall be reduced to the extent benefits of the same type are received by you, your spouse or any eligible dependent from any other person during such period, and provided, further, that you shall have the obligation to notify the Company that you or they are receiving such benefits. |
c. | Notwithstanding any provision in this Agreement to the contrary, if you have not delivered to the Company an executed Release, which Release has become irrevocable, on or before the sixtieth (60th) day after the date of your Separation from Service, you shall forfeit all of the payments and benefits described in this Section 9 and shall be obligated to repay any such amounts (or the value thereof) that were provided prior to such time. |
/s/ Jean-Michel Malek |
(Signature) |
Jean-Michel Malek |
(Print Name) |
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
;]+]RWU%3_QAUVV?5\-J8ZQWVBH[6-+C M )_-8'.57'$QS1!Z2;.0\6*1'6+YG^ =]HP*768&426,J87>C9])U.RL._0O\ IT?N?S/^B5;Z MIXV4SZR].<_'N8T6/ESJWM _16\N I265T/J9R M:_LU[IR*A([ESN*W+R'LIJ>]UCQH#8X<#<==R!EMIND1WUV>T27+_LC MK7@[_MX_^26CT7"S\:ZUV5.US6ALOWZ@NGND)&]E$#NZZ2Y7K5EC>IWQ8]K1 MLT#G ?0;V!4OV1UKP=_V\?\ R27%J=%
G)E4WI.5&-Z:V,Y9"(_/B \>#IX
M;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B
M92!835 @0V]R92 U+C M8S V," V,2XQ,S0W-S A!\P>M'WWE[UB+U@J?\
M@//_ ,L9?^A&][7XE^WK3?"?LZ^B=_W21_\ ,=7_ ,[5[P7_ /!F?]3W_M;Z
MSD_\%I_U(O\ M5Z__]6I?WTAZYQ=>]^Z]UM]_P#"9_\ YDI\IO\ Q,.S_P#W
M@J?WB]]X#_DK\N?\\K_]7#UD][ _\DGF/_GJ3_JWT?#^:;_*VQO\PC'=;;AV
MIO#!]8]O==U59B5WAF<'5YK'9_K_ "JRU=9MC+4N-JJ*NDFQF<6.KQTODTTY
MFJE*GSD@&^W/N+)R/)?P7-J]QM 969?#)H2,"HQ\^N.4
M?8O8N&S>S:G*8'<6/SN)K:#*8RBRF/KII,=51?;5$GB@FF>/Q&92LFG]N320
M0;>_.;>Y1X"ZLK @@$''7E\:W=)@K*RFH)!&>M=[M[K/+]0=A[CV%E_)*V(J
M]>+R$B:!F,#5ZIL/E4MZ":FEL)0O"5"2)]5/N.KRU>SN9+=_(X/J/(_ZO/H>
M6EPMU;QSKYC(]#YC_5Y=!Y34U365$-)1TU165=3(L--2TD$M34U$SFR104\"
M/--*Y^BJI8_@>TP!) J3TH) !)-!T:#JCX?=S=G9*C^\VYD-B;8=XI*[0!YJ'I0>OA[I'Q,?/A]I'Y0?OQ_J(!4@02!L()@@Q"#P(1PA
M2"%U(:$ASB'[(BR4
[_M
MWAC/_$U]M_\ NTQWO#WWP_Y7F3_GD@_P'K,#V2_Y4>/_ )ZYO\(ZO#]Q!U+O
M7O?NO=?-K_F,?]E]_,K_ ,6,[-_]W\_O/;D3_E2N5?\ G@B_X[U@9SU_RNG-
M7_/=+_Q[HF?L5]!7K8M_X37_ /95?R"_\5\HO_?C[=]P5[^?\JWLG_/^K3
M=3G["?\ *Q[W_P \(_ZNKUN9^\4^LJNM23^?!_+4.W,AF/G/T?@+8'*U$
M:]95^S/.O[VVX\L;C-7<;1*Q$G,D(P!GBT6%.MB/W!G4Y=>]^Z]U[W
M[KW1;/F7_P!DA?*C_P 5S[L_]]KN7V?\J?\ *T
HJ#@GKYT7R?\ C;V3\2>[
MMZ]$=J42P[DVC6AJ'+TT4L>'WAM>N:23;V\]OO*-4F(SU&FL*27IJA):>3]V
M%P,Z^7M_L.9MHM-YVUZP2C*GXD%&W])3^T488(ZP8YAV&_Y9W>[V;<4I<1
M'!'PNA^&1?Z+#]AJIR#T /LZZ)>O>_=>ZP5/_ >?_EC+_P!"-[VOQ+]O6F^$
M_9U]$[_NDC_YCJ_^=J]X+_\ @S/^I[_VM]9R?^"T_P"I%_VJ]?_0J7]](>N<
M77O?NO=8WBBD(,D:.1P"Z*Q _H+@V][!(X'K1 /$=M:5].O?;4__ !PA_P"I2?\ 1OOVIOXCU[2OIU[[:G_XX0_]2D_Z-]^U
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MX;,PQO*B%344IE@)T2M<0\K_Z,-E_S@B_Z!Z[_ -E5^+__ 'C?
MT+_Z)_KW_P"QWW[^LG,/_1^O?^<\O_076_ZN
ARI_P H_G]G5ONU]SX'>>W\3NG;&2I\O@
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end
0 $
M 0 'G0 $0 0
M 0 0 &YU;&P " !F)O=6YD '!A8VME="!B
M96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ